This week at Retraction Watch featured a heartfelt essay by John Ioannidis on what he called the hijacking of evidence-based medicine, as well as the story of a peer reviewer who stole text for his own paper. Here’s what was happening elsewhere:
- “When it comes to publishing research, I have to come clean,” says Philip Moriarty. “I’m a hypocrite.”
- “Many scientific ‘truths’ are, in fact, false,” writes Olivia Goldhill in Quartz.
- A “handful of biologists went rogue and published directly to [the] Internet.” Amy Harmon reports on #ASAPbio and preprints in The New York Times.
- “In a bold move against publication bias,” a group of psychologists have “thrown up their own file drawer,” writes Neuroskeptic.
- How did the New England Journal of Medicine’s Lisa Rosenbaum get confidential patient information? asks The Cancer Letter. Michelle Meyer raises one possibility. Update: Meyer reports in Forbes that NEJM now says Rosenbaum “was not reporting that the cancer was stage IV before the time of the initial fibroid surgery.”
- Does scientific fraud cause harm to people? You bet it does, we argue in our newest STAT column.
- Last week, we covered a paper on “simple abstracts.” Here’s Hilda Bastian’s take on that study.
- “Why is ClinicalTrials.gov still struggling?” asks Kent Anderson at The Scholarly Kitchen.
- “Why Retractions of Medical Studies Are Good For Medicine:” Our Ivan Oransky speaks to the Berkeley Wellness Letter.
- Missteps in Nephrology: Participate in a different kind of March Madness, aka Neph Madness.
- The World Anti-Doping Agency funds academics, makes them sign non-disclosure agreements, then refuses to let them publish, says Roger Pielke, Jr.
- When it comes to data, a new set of proposed guidelines advocates “being ‘intelligently open’, rather than ‘religiously open.'”
- How have scholarly journals converted to open access? A new report takes a look.
- In Part 2 of “Saving Scientists from the Scientists,” the BBC’s Alok Jha “looks at the practices and cultures undermining the integrity of scientific research.”
- This is great: Elies Bik writes captions for a series of lab stock photos.
- “Should all research papers be free?” asks Kate Murphy. (New York Times)
- “When good nonprofits collide:” Lenny Teytelman looks at the clash between PLOS and scientific societies.
- “You can’t retract a designer baby,” writes Paul Knoepfler of CRISPR.
- “The research discipline of scholarly communication is not well-recognized,” says Danny Kingsley.
- What does psychology’s reproducibility “crisis mean for the future of science?” asks Brian Resnick in Vox.
- Nature Chemistry editor Stuart Cantrill was surprised to see his own images in an email from another journal, unattributed. But they apologized and fixed the error nearly immediately.
- “Is there ‘Institutionalised Corruption’ in Science?” asks Jeremy Garwood in Lab Times.
- There is “no evidence that industry funding increases misconduct,” Bruce Gingles writes in a letter to The Chronicle of Higher Education.
- A new publisher is promising publication within 20 days, Tansu Küçüköncü reports.
- “Can we trust food surveys?” The BBC talks to FiveThirtyEight’s Christie Aschwanden.
- Educating “citizen scientists” can “improve knowledge of basic research concepts and ultimately boost the integrity of scientific research,” according to a new study.
Retractions Outside of the Scientific Literature
- Oops: “A biotech company made an unfortunate typo saying it’s under criminal investigation,” Rebecca Robbins reports at STAT.
- A retraction of a retraction, from Thony Christie.
- Canada’s Senate “hired a private law firm to seek retractions in a TV network story depicting routine budget deliberations as ‘another backroom meeting’ to divvy up public funds.” The network, Global News, rewrote the story. (sub req’d)
Re: “What does psychology’s reproducibility ‘crisis mean for the future of science?’ asks Brian Resnick in Vox.” Very little, in my opinion – as I do not believe that psychology really qualifies as a true science. I see it as a (wonderful) humanities subject that sometimes uses science-like methods. (The same goes for sociology and geography.)
It’s thoroughly unclear to me what this tweet adds to anything. The issue is Rosenbaum’s assertion that Reed had stage IV disease before the morcellation.
I see that Meyer has taken to Forbes to contend (at somewhat tedious length, IMO) that “Reed’s LMS was stage IV” is “grammatically ambiguous.”
I find no small irony in the Harvard Library Office for Scholarly Communication’s producing an effectively unreadable document. Multiple vertical scroll bars have been a hallmark of incompetent design for many years, and there’s apparently no way to view it in its entirety. Moreover, it’s necessary to have a second window open to follow along with the references.
Is the linke in this line, “When it comes to data, a new set of proposed guidelines advocates “being ‘intelligently open’, rather than ‘religiously open.’”” correct? I have looked at the manuscript that is linked to but cannot find the words “intelligently” or “religiously” in it? I am not sure the link is correct.
Yes, that’s a line from the press release describing the new guidelines: https://www.wageningenur.nl/en/newsarticle/FAIR-guiding-principles-published-in-journal-of-the-Nature-Publishing-Group-family-.htm
Thanks for that information – it might not hurt to indicate that in the comment as well.
Done.